Most authors are employees of the Paris hospital system and the INSERM governmental research institute . Both refractory to HCQ with a strong conflict of interest in proving HCQ would not have saved lives post-hoc. Hence the glaring lack of cohort matching on ICU admission?
-
-
Show this thread
-
As a perfect illustration of Paris obstruction to HCQ and in complete contradiction with Dr Raoult's protocol, the Sbidian study shows that 51% of patients admitted in ICU after more than 24h (76/148) initiated the treatment only AFTER their ICU admission.
Show this thread
End of conversation
New conversation -
-
-
Actually even doing so (and counting people who received HCQ two hours before being admitted to ICU) you can still read positive results. Look at
@CorinneReverbel and@dperettiThanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
This Tweet is unavailable.
-
Well theyre killing us while they do it
End of conversation
-
-
-
Sorry for asking. But what does that mean for someone like me who's not an expert? Thanks
-
This means that even if the groups compared are poorly designed and not comparable without questionable adjustments, we clearly see a significant positive effect of the HCQ. Given the size of the control group, the groups could have been designed to be comparablepic.twitter.com/mAJzXOFF6z
- Show replies
New conversation -
-
-
Didier Raoult protocole is simple and easy: We've had a 97% cure for the COVID-19er since February. 1. Azithromycin 2. Zinc 3. Hydroxychloroquine 5 days later non contagious for 97% of patients period
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.